Basics Adaptive Biotechnologies Corporation IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.15B Activated in VL: True Average Daily Range Avg Daily Range: $0.61 | 3.27% Avg Daily Range (30 D): $0.39 | 2.44% Avg Daily Range (90 D): $0.35 | 2.55% Institutional Daily Volume Avg Daily Volume: 1.07M Avg Daily Volume (30 D): 1.46M Avg Daily Volume (90 D): 1.59M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 75 Institutional Trades Total Inst.Trades: 2,717 Avg Inst. Trade: $1.92M Avg Inst. Trade (30 D): $2.61M Avg Inst. Trade (90 D): $2.4M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.36M Avg Closing Trade (30 D): $3.64M Avg Closing Trade (90 D): $3.15M Avg Closing Volume: 144.16K     News Aug 6, 2025 @ 11:01 PM Why Adaptive Biotechnologies Stock Popped by Almos... Source: Eric Volkman Jul 25, 2025 @ 8:59 AM U.S. Minimal Residual Disease Testing Market Trend... Source: Researchandmarkets.Com May 30, 2025 @ 11:30 AM Adaptive Biotechnologies Highlights New Data at 20... Source: Adaptive Biotechnologies Corporation Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $.06 $-.17 Diluted EPS $.06 $-.17 Revenue $ $ 93.97M $ 58.88M Gross Profit $ $ 75.82M $ 40.88M Net Income / Loss $ $ 9.55M $ -25.59M Operating Income / Loss $ $ 10.29M $ -25.04M Cost of Revenue $ $ 18.16M $ 18M Net Cash Flow $ $ 11.84M $ -7.47M PE Ratio